| scholarly article | Q13442814 |
| P50 | author | Sheila E. Francis | Q38589785 |
| P2093 | author name string | Andrew H Baker | |
| John D McClure | |||
| Robert A McDonald | |||
| Song Wan | |||
| Eva van Rooij | |||
| Simon Kennedy | |||
| Brian C Cooley | |||
| Sarah J George | |||
| Katie M White | |||
| Junxi Wu | |||
| Crawford A Halliday | |||
| Keith E Robertson | |||
| Ruifaug Lu | |||
| P2860 | cites work | Murine model of neointimal formation and stenosis in vein grafts | Q47710842 |
| PTEN reduces cuff-induced neointima formation and proinflammatory cytokines. | Q54447341 | ||
| MicroRNA-133 controls vascular smooth muscle cell phenotypic switch in vitro and vascular remodeling in vivo. | Q54566995 | ||
| miR-21, miR-210, miR-34a, and miR-146a/b are up-regulated in human atherosclerotic plaques in the Tampere Vascular Study | Q57417408 | ||
| Distention promotes platelet and leukocyte adhesion and reduces short-term patency in pig arteriovenous bypass grafts | Q68718453 | ||
| Early mortality and morbidity of bilateral versus single internal thoracic artery revascularization: propensity and risk modeling | Q73536395 | ||
| Both donor and recipient origins of smooth muscle cells in vein graft atherosclerotic lesions | Q78327780 | ||
| Characterization of fibroblast-specific protein 1 in pulmonary fibrosis | Q81196614 | ||
| MicroRNA 21 regulates the proliferation of human adipose tissue-derived mesenchymal stem cells and high-fat diet-induced obesity alters microRNA 21 expression in white adipose tissues | Q83549847 | ||
| Antagonist of microRNA-21 improves balloon injury-induced rat iliac artery remodeling by regulating proliferation and apoptosis of adventitial fibroblasts and myofibroblasts | Q84080024 | ||
| MicroRNA-21 blocks abdominal aortic aneurysm development and nicotine-augmented expansion | Q24305799 | ||
| The knockout of miR-143 and -145 alters smooth muscle cell maintenance and vascular homeostasis in mice: correlates with human disease | Q24606673 | ||
| Stress-dependent cardiac remodeling occurs in the absence of microRNA-21 in mice | Q24623247 | ||
| MicroRNA-145, a novel smooth muscle cell phenotypic marker and modulator, controls vascular neointimal lesion formation | Q24650539 | ||
| The functions of animal microRNAs | Q27860621 | ||
| MicroRNA-21 regulates vascular smooth muscle cell function via targeting tropomyosin 1 in arteriosclerosis obliterans of lower extremities | Q28115033 | ||
| Long-term patency of saphenous vein and left internal mammary artery grafts after coronary artery bypass surgery: results from a Department of Veterans Affairs Cooperative Study | Q28211202 | ||
| An essential role of PDCD4 in vascular smooth muscle cell apoptosis and proliferation: implications for vascular disease | Q28578102 | ||
| Inactivation of the tumour suppressor, PTEN, in smooth muscle promotes a pro-inflammatory phenotype and enhances neointima formation | Q33795723 | ||
| A gene therapy strategy using a transcription factor decoy of the E2F binding site inhibits smooth muscle proliferation in vivo | Q34159206 | ||
| Modulation of K-Ras-dependent lung tumorigenesis by MicroRNA-21. | Q34271727 | ||
| Percutaneous coronary intervention versus coronary-artery bypass grafting for severe coronary artery disease | Q34948400 | ||
| MicroRNA-21 is overexpressed in human cholangiocarcinoma and regulates programmed cell death 4 and tissue inhibitor of metalloproteinase 3. | Q35070803 | ||
| Important triad in cardiovascular medicine: diabetes, coronary intervention, and platelet glycoprotein IIb/IIIa receptor blockade | Q35091273 | ||
| Mouse model of venous bypass graft arteriosclerosis | Q35753478 | ||
| The role of phosphoinositide-3 kinase and PTEN in cardiovascular physiology and disease | Q35846644 | ||
| miR-21 regulates chronic hypoxia-induced pulmonary vascular remodeling. | Q35850316 | ||
| Comparative effectiveness of revascularization strategies | Q36351313 | ||
| MicroRNA and vascular remodelling in acute vascular injury and pulmonary vascular remodelling | Q37953895 | ||
| Vein graft failure: current clinical practice and potential for gene therapeutics | Q37997898 | ||
| Long-term stabilization of vein graft wall architecture and prolonged resistance to experimental atherosclerosis after E2F decoy oligonucleotide gene therapy | Q38302443 | ||
| Efficacy and safety of edifoligide, an E2F transcription factor decoy, for prevention of vein graft failure following coronary artery bypass graft surgery: PREVENT IV: a randomized controlled trial | Q38411135 | ||
| Off-Pump coronary artery bypass surgery is associated with worse arterial and saphenous vein graft patency and less effective revascularization: Results from the Veterans Affairs Randomized On/Off Bypass (ROOBY) trial. | Q38471525 | ||
| On-pump versus off-pump coronary-artery bypass surgery | Q39108200 | ||
| MicroRNA expression signature and antisense-mediated depletion reveal an essential role of MicroRNA in vascular neointimal lesion formation | Q41166615 | ||
| Aortocoronary saphenous vein graft disease: pathogenesis, predisposition, and prevention | Q41729196 | ||
| Intimal proliferation in an organ culture of human saphenous vein | Q42124487 | ||
| Randomized trial to compare bilateral vs. single internal mammary coronary artery bypass grafting: 1-year results of the Arterial Revascularisation Trial (ART). | Q45277532 | ||
| Sustained reduction of vein graft neointima formation by ex vivo TIMP-3 gene therapy | Q45873233 | ||
| P433 | issue | 22 | |
| P304 | page(s) | 1636-1643 | |
| P577 | publication date | 2013-03-25 | |
| P1433 | published in | European Heart Journal | Q2286839 |
| P1476 | title | miRNA-21 is dysregulated in response to vein grafting in multiple models and genetic ablation in mice attenuates neointima formation | |
| P478 | volume | 34 |
| Q34129012 | A selective microRNA-based strategy inhibits restenosis while preserving endothelial function |
| Q27316157 | Adventitial vessel growth and progenitor cells activation in an ex vivo culture system mimicking human saphenous vein wall strain after coronary artery bypass grafting |
| Q52690622 | Association between hypertension and circulating vascular-related microRNAs. |
| Q90481516 | Coronary artery mechanics induces human saphenous vein remodelling via recruitment of adventitial myofibroblast-like cells mediated by Thrombospondin-1 |
| Q34456871 | Crosstalk between TGF-β/Smad3 and BMP/BMPR2 signaling pathways via miR-17-92 cluster in carotid artery restenosis |
| Q58588641 | Elucidating the contributory role of microRNA to cardiovascular diseases (a review) |
| Q39301458 | Epigenetics and Vascular Diseases: Influence of Non-coding RNAs and Their Clinical Implications. |
| Q64290782 | Exosomes derived from M1 macrophages aggravate neointimal hyperplasia following carotid artery injuries in mice through miR-222/CDKN1B/CDKN1C pathway |
| Q90162787 | Glioblastoma-Associated Microglia Reprogramming Is Mediated by Functional Transfer of Extracellular miR-21 |
| Q33673175 | High expression of ubiquitin-specific peptidase 39 is associated with the development of vascular remodeling |
| Q36198491 | Local Anti-miR Delivery: The Latest in the Arsenal of Drug-Eluting Stents. |
| Q36004612 | Local MicroRNA Modulation Using a Novel Anti-miR-21-Eluting Stent Effectively Prevents Experimental In-Stent Restenosis |
| Q42244816 | Macrophage-stimulated microRNA expression in mural cells promotes transplantation-induced neointima formation |
| Q33864736 | MiR-551b-5p Contributes to Pathogenesis of Vein Graft Failure via Upregulating Early Growth Response-1 Expression. |
| Q91637424 | MicroRNA-21 and Venous Neointimal Hyperplasia of Dialysis Vascular Access |
| Q88151490 | MicroRNA-21 and the Vulnerability of Atherosclerotic Plaques |
| Q50923481 | MicroRNA-33 protects against neointimal hyperplasia induced by arterial mechanical stretch in the grafted vein. |
| Q38828033 | Nanomedicine Meets microRNA: Current Advances in RNA-Based Nanotherapies for Atherosclerosis |
| Q38235041 | Novel potential targets for prevention of arterial restenosis: insights from the pre-clinical research. |
| Q90151128 | Reconstruction of a lncRNA-Associated ceRNA Network in Endothelial Cells under Circumferential Stress |
| Q35649420 | Reducing In-Stent Restenosis: Therapeutic Manipulation of miRNA in Vascular Remodeling and Inflammation |
| Q28910228 | Resveratrol-Induced Vascular Progenitor Differentiation towards Endothelial Lineage via MiR-21/Akt/β-Catenin Is Protective in Vessel Graft Models |
| Q57297217 | Role of flow-sensitive microRNAs and long noncoding RNAs and in vascular dysfunction and atherosclerosis |
| Q64355505 | Role of flow-sensitive microRNAs and long noncoding RNAs in vascular dysfunction and atherosclerosis |
| Q34214431 | Role of flow-sensitive microRNAs in endothelial dysfunction and atherosclerosis: mechanosensitive athero-miRs |
| Q64245435 | Substantial Dysregulation of miRNA Passenger Strands Underlies the Vascular Response to Injury |
| Q60922525 | TGFβ, smooth muscle cells and coronary artery disease: a review |
| Q59813054 | Targeting Non-coding RNA in Vascular Biology and Disease |
| Q92047061 | The Role of MicroRNA-21 in Venous Neointimal Hyperplasia: Implications for Targeting miR-21 for VNH Treatment |
| Q90886268 | The salient role of microRNAs in atherogenesis |
| Q47100300 | Upregulation of miR-126-3p promotes human saphenous vein endothelial cell proliferation in vitro and prevents vein graft neointimal formation ex vivo and in vivo |
Search more.